Board of Advisors

About the Institute

Purpose
Administration

Board of Advisors

Board Profiles

Research

Current Projects
Recently Completed Projects
Dissemination

Visiting Policy Researchers

Merwyn R. Greenlick, Ph.D.
Representative, Oregon House of Representatives
Phone: (503) 986-1433 Interim Phone: (503) 297-2416
E-mail: rep.mitchgreenlick@state.or.us
Oregon House of Representatives Website: http://www.leg.state.or.us/greenlick/home.htm

Merwyn R. Greenlick, Ph.D., is professor emeritus and past chair of the Department of Public Health and Preventive Medicine, School of Medicine, Oregon Health & Science University.   He also directs the Oregon Health Policy Institute.  In 2002 Mitch was elected to the Oregon House of Representatives.  Until July, 1995, he was director of the Kaiser Permanente Center for Health Research (CHR) and Vice President for Research, Kaiser Foundation Hospitals.  Dr. Greenlick received his Ph.D. in medical care organization from the University of Michigan with specializations in sociology, social psychology and research design.  He was instrumental in starting the CHR in 1964 and was its director for more than 30 years.  He has served as research advisor to many projects throughout the country and as an advisor to several foreign government research and medical care projects.

He was elected to the Institute of Medicine of the National Academy of Sciences in 1971.  He has served on a number of Institute of Medicine Study Committee s, including the steering committee on the future of clinical research, and chaired the IOM's Committee on Community-Based Drug Treatment, and the IOM Committee for a National Center on War-Related Illnesses and Post-deployment Health Issues.  He has served on a variety of NIH review panels, including the Health Services Development Panel. Dr. Greenlick was a Senior Fellow at the Center for Advanced Study in the Behavioral Sciences at Stanford during 1995-96.  He currently is on the board of three charitable foundations.

Dr. Greenlick's research has been in the areas of large-scale demonstration projects relating to the organization and financing of medical care and behavioral interventions in disease prevention.  He was a coprincipal investigator for the Medicare Prospective Payment Demonstration Project ("Medicare Plus"), which provided care to over 7,600 Medicare beneficiaries on a capitation basis.  He is currently the principal investigator of the Kaiser Permanente site of the Social HMO project, which is investigating the financial feasibility of providing a comprehensive range of long-term care services for the "frail" elderly.   He serves as the chair of the research committee of the national Social HMO Research Consortium.

In addition to his work with large-scale demonstrations, Dr. Greenlick has had extensive experience in clinical trials, both at the local and national levels, and has provided considerable leadership at the national level.  He recently stepped down as principal investigator for the Oregon Node of the National Clinical Trials Network of the National Institute on Drug Abuse.  He was principal investigator for the Dietary Intervention Study in Children and chair of the national design and analysis committee.  He was a co-investigator on the clinical trial relating to the treatment of systolic hypertension among the elderly (SHEP) and was Portland project director for the Multiple Risk Factor Intervention Trial (MRFIT) and co-principal investigator for the Beta-Blocker Heart Attack Trial, both sponsored by the NHLBI.

Dr. Greenlick is a Distinguished Fellow of the Association for Health Services Research (now the Academy for Health Services Research and Health Policy) and, in 1994, received the Association's President's Award for his lifetime contributions to the field.